September 22, 2023
RegMed Investors’ (RMi) pre-open: look for “some” buy points
September 21, 2023
RegMed Investors’ (RMi) pre-open: Wherefore art thou?
September 20, 2023
RegMed Investors’ (RMi) pre-open: brace
September 19, 2023
RegMed Investors’ (RMi) pre-open: Sector share pricing is disconnected from everything
September 18, 2023
RegMed Investors’ (RMi) pre-open: who has a share pricing compass or even a barometer?
September 15, 2023
RegMed Investors’ (RMi) pre-open: understanding perception
September 14, 2023
RegMed Investors’ (RMi) pre-open: the known unknowns
September 13, 2023
RegMed Investors’ (RMi) pre-open: try catching fog in a glass
September 12, 2023
RegMed Investors’ (RMi) pre-open: show me the money
September 11, 2023
RegMed Investors’ (RMi) pre-open: The September Effect
September 8, 2023
RegMed Investors’ (RMi) pre-open: reverse the sector’s downer curse
September 7, 2023
RegMed Investors’ (RMi) pre-open: Hope is not a good investment strategy
September 6, 2023
RegMed Investors’ (RMi) pre-open: risk gets riskier
September 5, 2023
RegMed Investors’ (RMi) pre-open: a challenging September ahead?
September 1, 2023
RegMed Investors’ (RMi) pre-open: patterns exist and then they don’t
August 31, 2023
RegMed Investors’ (RMi) pre-open: gains and losses
August 30, 2023
RegMed Investors’ (RMi) pre-open: the Icarus metaphor
August 29, 2023
RegMed Investors’ (RMi) pre-open: timing
August 28, 2023
RegMed Investors’ (RMi) pre-open: musical chairs
August 25, 2023
RegMed Investors’ (RMi) pre-open: share pricing versus Jerome
August 24, 2023
RegMed Investors’ (RMi) pre-open: anticipation versus expectation
August 23, 2023
RegMed Investors’ (RMi) pre-open: the outlook for cell and gene therapy equities remains challenging
August 22, 2023
RegMed Investors’ (RMi) pre-open: risk involves uncertainty
August 21, 2023
RegMed Investors’ (RMi) pre-open: it’s time to dive into the sector’s share pricing
August 18, 2023
RegMed Investors’ (RMi) pre-open: a set-up for ending the week on a weak note
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors